Swiss scientists have developed a vaccine for cats that can protect animal lovers allergic to them.
Swiss-based HypoPet AG stated that a newly developed vaccine, called HypoCat, works by 'immunizing cats against their major allergen, ie. Fel d 1 ”, an allergen found in cat dander. A report by Journal of Allergy and Clinical Immunology states that ten percent of people are allergic to this particular dandruff.
HypoPet AG CEO Gary Jennings said the vaccine produces high levels of antibodies in the cat, adding that "These antibodies can bind and neutralize the Fel d1 allergen produced by animals."
"The vaccine would help for those with cat allergies to avoid typical reactions such as rashes, nasal congestion and irritated eyes while reducing the risk of exacerbation. asthma or the development of chronic respiratory problems, "reports New York Post .
Jennings said the company is working with European and American regulators," hoping to release this much-needed product on the market. "
In a press release, HypoPet writes that allergies to cats are one of the main reasons for people to take their cats to a shelter or abandon them altogether.
The press release states:
suffering from owners, friends and relatives is the leading cause of cat abandonment.Unfortunately, of the 3.4 million cats abandoned annually at cat shelters in the US, approximately 1.4 million of these animals are euthanized. for abandoning cats in urban and local environments.
HypoPet added, h is to reduce "pet allergenicity", cat lovers will avoid the difficulty of being forced to abandon their pet entirely.  "To achieve this, HypoPet uses its innovative virus-like particle vaccination technology as a means
Reports say that the company has not seen long-term or severe side effects in the cats tested. This is due to the fact that cats are already naturally low in Fel d 1 and the protein does not perform any vital function inside the animals themselves.
If all goes according to plan, Jennings said HypoPet hopes to have the vaccine on the market by 2022.